Presentation is loading. Please wait.

Presentation is loading. Please wait.

Periop. Cases on Endocrine Disorders Thomas Maniatis Dec. 16, 2010.

Similar presentations


Presentation on theme: "Periop. Cases on Endocrine Disorders Thomas Maniatis Dec. 16, 2010."— Presentation transcript:

1 Periop. Cases on Endocrine Disorders Thomas Maniatis Dec. 16, 2010

2 Conflicts of Interest None

3 Case 65 female DM2 on glyburide 10 bid, pioglitazone 30 qd, metformin 1g bid Cataract OR Cholecystecomy Colectomy for colon CA

4 Issues to consider Patient Factors – Type of diabetes – Treatments: Diet, oral agents, insulin – Adequacy of control: loose, optimal, tight Surgical Factors – Minor, major – Timing – NPO starting when and lasting how long

5 Preop control and periop complications No high-quality data suggesting preop control impacts on periop complications Small study suggested that HbA1c >7% associated with increased wound infections Case-control study showed increased risk for wound infections if sugars > 11 (CABG)

6 Effects of surgery on glucose control Stress response causing increased glucose levels – glucagon, epi, GH, IL-6 and TNF-alpha

7 Goals of therapy Prevent ketoacidosis Avoid marked hyper / hypo glycemias Balanced fluids/electrolytes “Tight” vs. “loose” control – Varying evidence for “tight” control Improved outcomes in certain populations at cost of increased hypo’s – In general, “loose” control is acceptable

8 Case 65 female DM2 on metformin 1 g bid, N 10-0-0-10 Cataract OR Cholecystectomy Colectomy for CA Radical Neck Dissection for neck mass

9 Case 55 male DM1 on rapid 12-14-18-0, glargine 0-0-0-20 Cataract OR Neck Biopsy under GA (day surgery) Cholecystectomy CABG for CAD

10 IV Insulin How to write a protocol preop in stable patients When to transition from IV to SC postop How to transition from IV to SC postop

11 IV Insulin Protocols vary – Separate insulin/dextrose vs. combined GIK – Targets: tight vs. traditional – See Protocol Calculation of starting dose – Baseline total daily dose/24 – “safety margin” of 30- 50% – Dextrose depends on fluid sensitivity D5 vs. D10 – Monitoring, NPO, adjustments – Start early to stabilize dose by OR

12

13 IV insulin Intraop – Managed by anaesthesia Postop – Continue drips until no longer NPO – Plan transition to SC ahead of time

14 IV–SC insulin transition post-op Look at baseline dose pre-op Compare with current “needs” and take into account stressors (infection, etc.) and PO intake Hourly dose x 24 = total daily needs if control stable and eating well (and no infection…) Preferred transition to 3 injections of short- acting with meals and 1 intermediate-long acting before bed while in hospital

15 IV–SC insulin transition post-op Sliding scale – Traditional vs. adaptive sliding scale Monitor transition closely Modify baseline doses daily Closer to discharge, collapse regimen down to patient-appropriate protocol

16

17 Case 35 male Pituitary surgery for tumour Panhypopit. subsequently Cort. 25/12.5, thyroxin, testosterone Hernia repair Cholecystecomy Colectomy for mass

18 Case 65 female PMR on pred. 15/d Cataract Inguinal Hernia Esophageal resection for tumour

19 Case 50 male Mod-severe COPD on intermittent prednisone 4 x per year, inhaled steroids Exczema on topical steroids Cholecystectomy Pneumonectomy for tumour

20 Effects of surgery on steroid secretion Basal secretion – 8-10 mg/d of cortisol Minor surgery – 50 mg/d Major surgery – 75-100 mg/d (up to 200 mg/d in severe stress) Timing – Biggest surge is immediately post-op (reversal of anaesthesia, extubation)

21 Surgery and steroids Assess reason for steroid exposure – Primary adrenal or pituitary disease vs. other Assess magnitude of exposure – Dose and duration Consider further testing of axis – ACTH stimulation using the 250 microg dose – Uncertain meaning – Need adequate time Assess surgical “stress”

22 Effects of steroids on adrenal axis Likely not suppressed – Chronic use of < 5 mg of prednisone – Any patient on any dose of steroid for < 3 weeks Likely suppressed – Any patient on > 20 mg of prednisone for > 3 weeks – Any patient with clinical Cushing’s Intermediate – Everyone else!!

23 Surgery and steroids Supplement limited to immediate periop period – Hydrocortisone 50-100 mg IV pre-induction of anaesthesia, then 25-50 mg IV Q8h x 3 doses, then halve dose QD to baseline dose (or d/c) Be aware of risks of steroids periop – Infections – Impaired wound healing

24 Thyroid disorders and surgery Poor evidence base supporting recommendations Hypothyroidism – associated with intraop. hypotension in retrospective studies – Mild-mod: may choose to postpone elective surgery to optimize – Severe: only emergency surgery, give T4 and T3 urgently – Risk for myxedema coma Hyperthyroidism – Beta blockers to control HR – Thionamides – Risk for thyroid storm

25 Pheochromocytoma and surgery Medical preparation focuses on avoiding hypertensive crises Alpha blockade starting 7-10 days preop – phenoxybenzamine Followed by beta blockade 2-3 days preop Alternatives: Ca-channel blockers, metyrosine


Download ppt "Periop. Cases on Endocrine Disorders Thomas Maniatis Dec. 16, 2010."

Similar presentations


Ads by Google